Valerie Arnold
Launchpad Central (United States)(US)
Publications by Year
Research Areas
Attention Deficit Hyperactivity Disorder, Bipolar Disorder and Treatment, Autism Spectrum Disorder Research, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies
Most-Cited Works
- → A 9-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD(2012)47 cited
- → Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension(2025)44 cited
- → Efficacy and Safety of HLD200, Delayed-Release and Extended-Release Methylphenidate, in Children with Attention-Deficit/Hyperactivity Disorder(2017)38 cited
- → Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults(2004)36 cited
- → The Effects of Lisdexamfetamine Dimesylate on Emotional Lability in Children 6 to 12 Years of Age With ADHD in a Double-Blind Placebo-Controlled Trial(2012)33 cited
- → Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study(2017)26 cited
- → Redundant clothing: A readily observable marker for schizophrenia in the psychiatric emergency room population(1993)24 cited
- → Effect of Lisdexamfetamine Dimesylate on Parent-Rated Measures in Children Aged 6 to 12 Years With Attention-Deficit/Hyperactivity Disorder: A Secondary Analysis(2008)21 cited
- → Efficacy of Lemborexant in Adults ≥ 65 Years of Age with Insomnia Disorder(2024)12 cited
- → ADHD Symptom Rebound and Emotional Lability With Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years(2013)11 cited